Di Lisa Fabio, Bernardi Paolo
Dipartimento di Chimica Biologica, Università di Padova, Viale G. Colombo 3, 35121 Padova,
Cardiovasc Res. 2006 May 1;70(2):191-9. doi: 10.1016/j.cardiores.2006.01.016. Epub 2006 Feb 23.
Ischemia and post-ischemic reperfusion cause a wide array of functional and structural alterations of mitochondria. Although mitochondrial impairment is recognized as pivotal in determining loss of viability, the causal relationships among the various processes involved is ill defined. Nevertheless, a wide consensus exists in attributing a crucial role to opening of the mitochondrial permeability transition pore (PTP). Strong support for this concept has recently been provided by the reduced infarct size observed in mice lacking cyclophilin D. This protein located within the mitochondrial matrix favours PTP opening by increasing its sensitivity to Ca2+ in a process that is antagonized by cyclosporin A. Genetic approaches have also been used to demonstrate that adenine nucleotide translocase is not an essential component of the PTP. Here, we discuss our current understanding of the structure and function of PTP in the context of heart injury caused by ischemia and reperfusion.
缺血及缺血后再灌注会导致线粒体出现一系列功能和结构改变。尽管线粒体损伤被认为是决定细胞活力丧失的关键因素,但其中涉及的各种过程之间的因果关系仍不明确。然而,人们普遍认为线粒体通透性转换孔(PTP)的开放起着至关重要的作用。最近,在缺乏亲环蛋白D的小鼠中观察到梗死面积减小,这为这一概念提供了有力支持。这种位于线粒体基质内的蛋白质通过增加其对Ca2+的敏感性来促进PTP开放,而环孢素A可拮抗这一过程。遗传学方法也已用于证明腺嘌呤核苷酸转位酶不是PTP的必需组成部分。在此,我们将在缺血和再灌注引起的心脏损伤背景下,讨论我们目前对PTP结构和功能的理解。